The author explains why ear reconstruction is not enhancement surgery, and argues that the American system of health care reimbursement sometimes makes advocating for reimbursement part of treatment.
Because regulatory approval of cognitive enhancement drugs is likely, physicians may want to consider whether they would condone the practice for restoration of function only or for enhancement purposes as well.
Institutional review boards (IRBs) have the responsibility to ensure the protection of human-research subjects and are legally liable if they fail to do so.